AINGENS Partners with JOTO PR for AI Advancement

AINGENS is collaborating with JOTO PR Disruptors™ to enhance the development and application of evidence-first AI within regulated scientific fields. This partnership aims to accelerate scientific and medical content workflows while maintaining high standards of trust and accuracy. Facing increasing pressure in life sciences, AINGENS seeks to leverage AI responsibly to improve efficiency without compromising the integrity of critical data and research processes.